aprott Medicare coverage of weight loss drugs, if authorized, would increase federal spending by about $35B from 2026 to 2034, according to the Congressional Budget Office's analysis of an illustrative policy authorizing coverage in 2026. CBO estimates total direct federal costs of covering.